(S (NP (NP (NNP Predicting)) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (NP (NN cancer) (NNS cells)) (PP (IN to) (NP (NNS drugs))))))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN problem)) (PP (IN in) (NP (NNS pharmacogenomics))))) (. .))
(S (NP (NP (JJ Recent) (NNS efforts)) (PP (IN in) (NP (NP (NN generation)) (PP (IN of) (NP (NP (JJ large) (NN scale) (NNS datasets)) (VP (VBG profiling) (NP (NP (NML (NN gene) (NN expression) (CC and) (NN drug)) (NN sensitivity)) (PP (IN in) (NP (NN cell) (NNS lines)))))))))) (VP (VBP have) (VP (VBN provided) (NP (DT a) (JJ unique) (NN opportunity)) (S (VP (TO to) (VP (VB study) (NP (DT this) (NN problem))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (CD one) (JJ major) (NN challenge)) (VP (VBZ is) (NP (NP (DT the) (JJ small) (NN number)) (PP (IN of) (NP (NP (NP (NNS samples)) (-LRB- -LRB-) (NP (NN cell) (NNS lines)) (-RRB- -RRB-)) (PP (VBN compared) (PP (IN to) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NP (NNS features)) (-LRB- -LRB-) (NP (NNS genes)) (-RRB- -RRB-)) (PP (ADVP (RB even)) (IN in) (NP (DT these) (JJ large) (NNS datasets)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP propose) (NP (NP (NP (DT a) (JJ collaborative) (NN filtering)) (-LRB- -LRB-) (NP (NN CF)) (-RRB- -RRB-)) (PP (IN like) (NP (NN algorithm)))) (PP (IN for) (S (VP (VBG modeling) (NP (NML (NN gene) (HYPH -) (NN drug)) (NN relationship)) (S (VP (TO to) (VP (VB identify) (NP (NP (NNS patients)) (ADJP (RBS most) (JJ likely))) (S (VP (TO to) (VP (VB benefit) (PP (IN from) (NP (DT a) (NN treatment))))))))))))) (. .))
(S (PP (IN Due) (PP (IN to) (NP (NP (DT the) (NN correlation)) (PP (IN of) (NP (NP (NN gene) (NNS expressions)) (PP (IN in) (NP (JJ different) (NN cell) (NNS lines)))))))) (, ,) (NP (DT the) (NML (NN gene) (NN expression)) (NN matrix)) (VP (VBZ is) (NP (NP (QP (RB approximately) (NML (JJ low) (HYPH -) (NN rank)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN drug) (NNS responses)) (VP (MD could) (VP (VB be) (VP (VBN estimated) (PP (IN from) (NP (NP (DT a) (VBN reduced) (NN dimension) (NN latent) (NN space)) (PP (IN of) (NP (DT the) (NN gene) (NN expression))))))))))))))) (. .))
(S (PP (IN Towards) (NP (DT this) (NN end))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ joint) (NML (JJ low) (HYPH -) (NN rank)) (NN matrix) (NN factorization)) (CC and) (NP (JJ latent) (NML (JJ linear) (NN regression)) (NN approach)))) (. .))
(S (NP (NP (NNS Experiments)) (PP (IN with) (NP (NP (NNS data)) (PP (IN from) (NP (NP (DT the) (NNP Genomics)) (PP (IN of) (NP (NP (NNP Drug) (NNP Sensitivity)) (PP (IN in) (NP (NNP Cancer) (NN database)))))))))) (VP (VBP are) (VP (VBN included) (S (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP (DT the) (JJ proposed) (NN method)) (VP (MD can) (VP (VB predict) (S (NP (NML (NN drug) (HYPH -) (NN gene)) (NNS associations)) (ADJP (ADJP (JJR better)) (PP (IN than) (NP (DT the) (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NNS methods)))))))))))))) (. .))
